147 related articles for article (PubMed ID: 1347749)
1. Overexpression of multidrug resistance-associated p170-glycoprotein in acute non-lymphocytic leukemia.
Michieli M; Damiani D; Geromin A; Michelutti A; Fanin R; Raspadori D; Russo D; Visani G; Dinota A; Pileri S
Eur J Haematol; 1992 Feb; 48(2):87-92. PubMed ID: 1347749
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications.
Michieli M; Damiani D; Ermacora A; Masolini P; Raspadori D; Visani G; Scheper RJ; Baccarani M
Br J Haematol; 1999 Feb; 104(2):328-35. PubMed ID: 10050716
[TBL] [Abstract][Full Text] [Related]
3. A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivatives.
Michieli M; Michelutti A; Damiani D; Pipan C; Raspadori D; Lauria F; Baccarani M
Leuk Lymphoma; 1993 Feb; 9(3):255-64. PubMed ID: 8097129
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression.
Bodey B; Taylor CR; Siegel SE; Kaiser HE
Anticancer Res; 1995; 15(6B):2461-8. PubMed ID: 8669809
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance (MDR) gene expression in acute non lymphoblastic leukemia: sequential analysis.
Marie JP; Legrand O; Russo D; Zhou D; Suberville AM; Zittoun R
Leuk Lymphoma; 1992 Nov; 8(4-5):261-5. PubMed ID: 1363283
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical detection of the p170 multidrug resistance (MDR) and the p53 tumor suppressor gene proteins in human breast cancer cells: clinical and therapeutical significance.
Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE
Anticancer Res; 1997; 17(2B):1311-8. PubMed ID: 9137491
[TBL] [Abstract][Full Text] [Related]
7. P170 (Pgp) expression in leukemic cells after therapeutic exposure to arabinosyl cytosine.
Grimaz S; Damiani D; Michieli M; Sperotto A; Masolini P; Baccarani M
Adv Clin Path; 1998 Jan; 2(1):59-64. PubMed ID: 10358333
[TBL] [Abstract][Full Text] [Related]
8. [The clinical significance of lung resistance-related protein gene (lrp), multidrug resistance-associated protein gene (mrp) and mdr-1/p170 expression in acute leukemia].
Zhao Y; Yu L; Lou F; Wang Q; Pu J; Zhou Q
Zhonghua Nei Ke Za Zhi; 1999 Nov; 38(11):760-3. PubMed ID: 11798719
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric assessment of multidrug resistance (MDR) phenotype in acute myeloid leukaemia.
Hart SM; Ganeshaguru K; Lyttelton MP; Prentice HG; Hoffbrand AV; Mehta AB
Leuk Lymphoma; 1993 Oct; 11(3-4):239-48. PubMed ID: 7903178
[TBL] [Abstract][Full Text] [Related]
10. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukaemia.
Grey M; Borg AG; Wood P; Burgess R; Fisher A; Yin JA
Leuk Res; 1997 Sep; 21(9):867-74. PubMed ID: 9393602
[TBL] [Abstract][Full Text] [Related]
11. P170 glycoprotein expression and impaired anthracycline retention in chronic myeloid leukaemia.
Damiani D; Michieli M; Michelutti A; Fanin R; Russo D; Baccarani M
Leuk Lymphoma; 1995 Apr; 17(3-4):289-94. PubMed ID: 8580798
[TBL] [Abstract][Full Text] [Related]
12. Cellular and pharmacologic aspects of drug resistance in acute myeloid leukemia.
Ross DD
Curr Opin Oncol; 1991 Feb; 3(1):21-9. PubMed ID: 1675126
[TBL] [Abstract][Full Text] [Related]
13. The expression of the multidrug resistance related glycoprotein in adult acute lymphoblastic leukemia.
Savignano C; Geromin A; Michieli M; Damiani D; Michelutti A; Melli C; Fanin R; Baccarani M
Haematologica; 1993; 78(5):261-3. PubMed ID: 7906239
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the mdr1 gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin-A.
Nooter K; Sonneveld P; Oostrum R; Herweijer H; Hagenbeek T; Valerio D
Int J Cancer; 1990 Feb; 45(2):263-8. PubMed ID: 1968051
[TBL] [Abstract][Full Text] [Related]
15. Plasma cell P170 expression and response to treatment in multiple myeloma.
Patriarca F; Melli C; Damiani D; Michieli M; Michelutti A; Cavo M; Baccarani M
Haematologica; 1996; 81(3):232-7. PubMed ID: 8767528
[TBL] [Abstract][Full Text] [Related]
16. The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leukaemia.
Michieli M; Raspadori D; Damiani D; Geromin A; Gallizia C; Michelutti A; Fanin R; Fasola G; Russo D; Tazzari P
Br J Haematol; 1991 Apr; 77(4):460-5. PubMed ID: 1673863
[TBL] [Abstract][Full Text] [Related]
17. Multifactorial drug-resistance phenomenon in acute leukemias: impact of P170-MDR1, LRP56 protein, glutathione-transferases and metallothionein systems on clinical outcome.
Goasguen JE; Lamy T; Bergeron C; Ly Sunaram B; Mordelet E; Gorre G; Dossot JM; Le Gall E; Grosbois B; Le Prisé PY; Fauchet R
Leuk Lymphoma; 1996 Nov; 23(5-6):567-76. PubMed ID: 9031088
[TBL] [Abstract][Full Text] [Related]
18. Cytosine arabinoside and mitoxantrone treatment of relapsed or refractory childhood leukemia: initial response and relationship to multidrug resistance gene 1.
Wells RJ; Odom LF; Gold SH; Feusner J; Krill CE; Waldron P; Moulton TA; Knoppell E; White ML; Cairo MS
Med Pediatr Oncol; 1994; 22(4):244-9. PubMed ID: 7906380
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of P-glycoprotein expression in haematological malignancies.
Nooter K; Sonneveld P
Leuk Res; 1994 Apr; 18(4):233-43. PubMed ID: 7909572
[TBL] [Abstract][Full Text] [Related]
20. Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia.
Pallis M; Turzanski J; Harrison G; Wheatley K; Langabeer S; Burnett AK; Russell NH
Br J Haematol; 1999 Feb; 104(2):307-12. PubMed ID: 10050713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
